4//SEC Filing
BRENNER LOUIS MD 4
Accession 0001209191-21-032076
CIK 0001624658other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:45 PM ET
Size
8.9 KB
Accession
0001209191-21-032076
Insider Transaction Report
Form 4
BRENNER LOUIS MD
See Remarks
Transactions
- Sale
Common Stock
2021-05-10$1.11/sh−25,215$27,989→ 203,322 total - Exercise/Conversion
Common Stock
2021-05-10+83,721→ 228,537 total - Exercise/Conversion
Restricted Stock Units
2021-05-10−83,721→ 125,582 total→ Common Stock (83,721 underlying)
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]40% shall vest on May 10, 2021 and the remaining 60% shall vest on November 10, 2021, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Allena Pharmaceuticals, Inc.
CIK 0001624658
Entity typeother
Related Parties
1- filerCIK 0001389500
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:45 PM ET
- Size
- 8.9 KB